United States (US) Molecular Method Market (2025-2031) | Value, Companies, Growth, Analysis, Size & Revenue, Competitive Landscape, Trends, Segmentation, Forecast, Industry, Outlook, Share

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Molecular Method Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Molecular Method Market - Industry Life Cycle

3.4 United States (US) Molecular Method Market - Porter's Five Forces

3.5 United States (US) Molecular Method Market Revenues & Volume Share, By Product, 2021 & 2031F

3.6 United States (US) Molecular Method Market Revenues & Volume Share, By Method, 2021 & 2031F

3.7 United States (US) Molecular Method Market Revenues & Volume Share, By End user, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing demand for personalized medicine and targeted therapies

4.2.2 Technological advancements in molecular diagnostic techniques

4.2.3 Rising prevalence of infectious diseases and chronic conditions

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for molecular diagnostic tests

4.3.2 High cost associated with molecular testing procedures

4.3.3 Limited awareness and adoption of molecular methods in certain healthcare settings

6.1 United States (US) Molecular Method Market, By Product

6.1.1 Overview and Analysis

6.1.2 United States (US) Molecular Method Market Revenues & Volume, By Product, 2021- 2031F

6.1.3 United States (US) Molecular Method Market Revenues & Volume, By Instruments, 2021- 2031F

6.1.4 United States (US) Molecular Method Market Revenues & Volume, By Reagents & Consumables, 2021- 2031F

6.1.5 United States (US) Molecular Method Market Revenues & Volume, By Services, 2021- 2031F

6.2 United States (US) Molecular Method Market, By Method

6.2.1 Overview and Analysis

6.2.2 United States (US) Molecular Method Market Revenues & Volume, By Polymerase Chain Reaction, 2021- 2031F

6.2.3 United States (US) Molecular Method Market Revenues & Volume, By Immunoassays, 2021- 2031F

6.2.4 United States (US) Molecular Method Market Revenues & Volume, By Biosensors, 2021- 2031F

6.2.5 United States (US) Molecular Method Market Revenues & Volume, By Microarrays, 2021- 2031F

6.2.6 United States (US) Molecular Method Market Revenues & Volume, By Others, 2021- 2031F

6.3 United States (US) Molecular Method Market, By End user

6.3.1 Overview and Analysis

6.3.2 United States (US) Molecular Method Market Revenues & Volume, By Pharmaceutical & Biotechnology Industries, 2021- 2031F

6.3.3 United States (US) Molecular Method Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F

6.3.4 United States (US) Molecular Method Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F

6.3.5 United States (US) Molecular Method Market Revenues & Volume, By Others, 2021- 2031F

7.1 United States (US) Molecular Method Market Export to Major Countries

7.2 United States (US) Molecular Method Market Imports from Major Countries

8.1 Adoption rate of molecular methods in clinical practice

8.2 Number of FDA approvals for new molecular diagnostic tests

8.3 Investment in research and development for molecular diagnostic technologies

8.4 Percentage of healthcare facilities offering molecular testing services

9.1 United States (US) Molecular Method Market Opportunity Assessment, By Product, 2021 & 2031F

9.2 United States (US) Molecular Method Market Opportunity Assessment, By Method, 2021 & 2031F

9.3 United States (US) Molecular Method Market Opportunity Assessment, By End user, 2021 & 2031F

10.1 United States (US) Molecular Method Market Revenue Share, By Companies, 2024

10.2 United States (US) Molecular Method Market Competitive Benchmarking, By Operating and Technical Parameters